51![Guidance for Industry: Efficacy Studies to Support Marketing of Fibrin Sealant Products Manufactured for Commercial Use Guidance for Industry: Efficacy Studies to Support Marketing of Fibrin Sealant Products Manufactured for Commercial Use](https://www.pdfsearch.io/img/41fbc0979327cb0b4f9b4e991a411c38.jpg) | Add to Reading ListSource URL: www.fda.govLanguage: English |
---|
52![NovoSeven RT Coagulation Factor VIIa (Recombinant) Room Temperature Stable, Lyophilized Powder NovoSeven RT Coagulation Factor VIIa (Recombinant) Room Temperature Stable, Lyophilized Powder](https://www.pdfsearch.io/img/5fbe97fd2c55d8987ed6b7af32ffb230.jpg) | Add to Reading ListSource URL: www.fda.govLanguage: English |
---|
53![Focusing on Coagulapathy & Wound Healing The Next Generation of Fibrin-Based Hemostatic Technology Focusing on Coagulapathy & Wound Healing The Next Generation of Fibrin-Based Hemostatic Technology](https://www.pdfsearch.io/img/b330c2a61204e188dfbd2830b5fdb27a.jpg) | Add to Reading ListSource URL: www.fda.govLanguage: English |
---|
54![HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use FEIBA safely and effectively. See full prescribing information for FEIBA. FEIBA, Anti-Inhibitor Coagulant Complex Fo HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use FEIBA safely and effectively. See full prescribing information for FEIBA. FEIBA, Anti-Inhibitor Coagulant Complex Fo](https://www.pdfsearch.io/img/6407d34ccceefd897ef410cb76166d15.jpg) | Add to Reading ListSource URL: www.fda.govLanguage: English |
---|
55![Hemostatic Products Regulated by CBER Nisha Jain, M.D. Chief, Clinical Review Branch Division Of Hematology Clinical Review OBRR/CBER/FDA Hemostatic Products Regulated by CBER Nisha Jain, M.D. Chief, Clinical Review Branch Division Of Hematology Clinical Review OBRR/CBER/FDA](https://www.pdfsearch.io/img/78e2742f2d67993cd571f47eae3aeae2.jpg) | Add to Reading ListSource URL: www.fda.govLanguage: English |
---|
56![JRC-IRMM’s reference material for C-reactive protein - A worldwide anchor point in clinical chemistry JRC-IRMM’s reference material for C-reactive protein - A worldwide anchor point in clinical chemistry](https://www.pdfsearch.io/img/2b938123b0fa9b2bb9c24d21312a07d8.jpg) | Add to Reading ListSource URL: ec.europa.euLanguage: English - Date: 2013-04-03 07:28:21
|
---|
57![東京大学ナノバイオ国際研究教育拠点セミナー #02 C2CNB Seminar Series Inter national Core Research Center for NanoBio , The University of Tokyo 東京大学ナノバイオ国際研究教育拠点セミナー #02 C2CNB Seminar Series Inter national Core Research Center for NanoBio , The University of Tokyo](https://www.pdfsearch.io/img/55534e3408f9ec850645f05618e70a38.jpg) | Add to Reading ListSource URL: square.umin.ac.jpLanguage: English - Date: 2014-01-20 20:59:56
|
---|
58![Coagulation Factor IX (Recombinant) Benefix Coagulation Factor IX (Recombinant) Benefix](https://www.pdfsearch.io/img/d825798447f6afd4711fefae9e934f70.jpg) | Add to Reading ListSource URL: www.fda.govLanguage: English |
---|
59![SEKK Certifikace 2014 – hemokoagulace Divize EHK SEKK Certifikace 2014 – hemokoagulace Divize EHK](https://www.pdfsearch.io/img/b6c2acdef36d9105775022d4e448c00d.jpg) | Add to Reading ListSource URL: www.sekk.czLanguage: English - Date: 2014-05-14 15:49:21
|
---|
60![Final Review Memorandum Subject: BLA STN: [removed]Kamada-API [Alpha 1 Proteinase Inhibitor (Human) Intravenous] Final Review Memorandum Subject: BLA STN: [removed]Kamada-API [Alpha 1 Proteinase Inhibitor (Human) Intravenous]](https://www.pdfsearch.io/img/26a505984e058502d38691fbb183684f.jpg) | Add to Reading ListSource URL: www.fda.govLanguage: English |
---|